Citation Impact
Citing Papers
Multi-Institutional Randomized Phase II Trial of Gefitinib for Previously Treated Patients With Advanced Non–Small-Cell Lung Cancer
2003 Standout
Sensing DNA Damage Through ATRIP Recognition of RPA-ssDNA Complexes
2003 StandoutScience
The Human Tim/Tipin Complex Coordinates an Intra-S Checkpoint Response to UV That Slows Replication Fork Displacement
2007 StandoutNobel
Tumor Cell–Derived and Macrophage-Derived Cathepsin B Promotes Progression and Lung Metastasis of Mammary Cancer
2006
Untangling the ErbB signalling network
2001 Standout
Amplification and Deletion of Topoisomerase IIα Associate with ErbB-2 Amplification and Affect Sensitivity to Topoisomerase II Inhibitor Doxorubicin in Breast Cancer
2000
Hallmarks of Cancer: The Next Generation
2011 Standout
BCRP/MXR/ABCP expression in topotecan-resistant human breast carcinoma cells
2000
Correlation between p53, c-erbB-2, and topoisomerase II? expression, DNA ploidy, hormonal receptor status and proliferation in 356 node-negative breast carcinomas: prognostic implications
1999
American Society of Clinical Oncology 2007 Update of Recommendations for the Use of Tumor Markers in Breast Cancer
2007 Standout
The multidrug-resistant phenotype associated with overexpression of the new ABC half-transporter, MXR (ABCG2)
2000
ERBB receptors and cancer: the complexity of targeted inhibitors
2005 Standout
EGFR Antagonists in Cancer Treatment
2008 Standout
Targeting hypoxia in cancer therapy
2011 Standout
Reactivity of Germ Cell Maturation Stage-Specific Markers in Spermatocytic Seminoma: Diagnostic and Etiological Implications
2001
Inflammation and Cancer: Triggers, Mechanisms, and Consequences
2019 Standout
Bone marrow cells regenerate infarcted myocardium
2001 StandoutNature
Cell-cycle checkpoints and cancer
2004 StandoutNature
Epidermal growth factor-related peptides and their receptors in human malignancies
1995 Standout
Accessories to the Crime: Functions of Cells Recruited to the Tumor Microenvironment
2012 Standout
The biology and management of non-small cell lung cancer
2018 StandoutNature
Dose calculation of anticancer drugs: a review of the current practice and introduction of an alternative.
1996 Standout
Toll-like receptor control of the adaptive immune responses
2004 Standout
HIF-1 mediates metabolic responses to intratumoral hypoxia and oncogenic mutations
2013 StandoutNobel
Adult Cardiac Stem Cells Are Multipotent and Support Myocardial Regeneration
2003 Standout
The immunohistochemical expression pattern of Chk2, p53, p19INK4d, MAGE‐A4 and other selected antigens provides new evidence for the premeiotic origin of spermatocytic seminoma
2003
Cetuximab Monotherapy and Cetuximab plus Irinotecan in Irinotecan-Refractory Metastatic Colorectal Cancer
2004 Standout
Macrophage Diversity Enhances Tumor Progression and Metastasis
2010 Standout
Stuck in Division or Passing through
2004
Erlotinib in Previously Treated Non–Small-Cell Lung Cancer
2005 Standout
Targeting multidrug resistance in cancer
2006 Standout
Spatial computation of intratumoral T cells correlates with survival of patients with pancreatic cancer
2017 StandoutNobel
Testicular germ-cell tumours in a broader perspective
2005 Standout
Antimicrobial peptides: pore formers or metabolic inhibitors in bacteria?
2005 Standout
p21 in cancer: intricate networks and multiple activities
2009 Standout
Clinical resistance to topoisomerase-targeted drugs
1998
HYPOXIA AND ANGIOGENESIS IN PANCREATIC CANCER
2006
Nrk, an X-linked Protein Kinase in the Germinal Center Kinase Family, Is Required for Placental Development and Fetoplacental Induction of Labor
2011 StandoutNobel
Comparison of the Ki-67 score and S-phase fraction as prognostic variables in soft-tissue sarcoma
1999
U1 snRNP regulates cancer cell migration and invasion in vitro
2020 Standout
Remodelling the extracellular matrix in development and disease
2014 Standout
Tumour hypoxia induces a metabolic shift causing acidosis: a common feature in cancer
2010
Death and anti-death: tumour resistance to apoptosis
2002 Standout
multifunctional enzymes in cancer
2006
NEW EMBO MEMBERS' REVIEW: The ErbB signaling network: receptor heterodimerization in development and cancer
2000 Standout
Cdc7-Dbf4 and the Human S Checkpoint Response to UVC
2007 StandoutNobel
Microenvironmental regulation of metastasis
2008 Standout
Dysregulated pH: a perfect storm for cancer progression
2011 Standout
An ATR- and Cdc7-Dependent DNA Damage Checkpoint that Inhibits Initiation of DNA Replication
2003
Protease-Activated Drug Development
2012
Colorectal carcinomas with high microsatellite instability: Defining a distinct immunologic and molecular entity with respect to prognostic markers
2000
The Ki-67 protein: From the known and the unknown
2000 Standout
Targeting DNA topoisomerase II in cancer chemotherapy
2009 Standout
Mitochondria as multifaceted regulators of cell death
2019 Standout
In vitro cell migration and invasion assays
2012
The emerging phenotype of the testicular carcinoma in situ germ cell
2003
2,4,6-Trisubstituted pyridines: Synthesis, topoisomerase I and II inhibitory activity, cytotoxicity, and structure–activity relationship
2007
Oncogene addiction in non-small cell lung cancer: Focus on ROS1 inhibition
2017
Tissue Microarrays: Applications in Neuropathology Research, Diagnosis, and Education
2002
The prognostic landscape of genes and infiltrating immune cells across human cancers
2015 Standout
Immunophenotype, proliferation, DNA ploidy, and biological behavior of gastrointestinal stromal tumors: A multivariate clinicopathologic study
1998
The spindle-assembly checkpoint in space and time
2007 Standout
Distinct functions of macrophage-derived and cancer cell-derived cathepsin Z combine to promote tumor malignancy via interactions with the extracellular matrix
2014
β-Catenin stabilization dysregulates mesenchymal cell proliferation, motility, and invasiveness and causes aggressive fibromatosis and hyperplastic cutaneous wounds
2002 Standout
Modulation of carbonic anhydrase activity and its applications in therapy
2004
Activation of Toll-Like Receptor 2 on Human Tracheobronchial Epithelial Cells Induces the Antimicrobial Peptide Human β Defensin-2
2003
Selective Killing of Hypoxia-Inducible Factor-1–Active Cells Improves Survival in a Mouse Model of Invasive and Metastatic Pancreatic Cancer
2009 StandoutNobel
Suramin: a novel antineoplastic agent with multiple potential mechanisms of action.
1993
Biology of Gastrointestinal Stromal Tumors
2004 Standout
Elevated Expression of the Apoptotic Regulator Mcl-1 at the Time of Leukemic Relapse
1998
Proteus mirabilis ZapA Metalloprotease Degrades a Broad Spectrum of Substrates, Including Antimicrobial Peptides
2004
Activatable Photosensitizers for Imaging and Therapy
2010 Standout
A molecular signature for anastasis, recovery from the brink of apoptotic cell death
2017
Tumor‐associated Carbonic Anhydrases and Their Clinical Significance
2006
Reactive oxygen species generating systems meeting challenges of photodynamic cancer therapy
2016 Standout
Normal development is an integral part of tumorigenesis in T cell-specific PTEN-deficient mice
2008 StandoutNobel
Structural Basis of Type II Topoisomerase Inhibition by the Anticancer Drug Etoposide
2011 StandoutScience
A novel DNA-dependent protein kinase inhibitor, NU7026, potentiates the cytotoxicity of topoisomerase II poisons used in the treatment of leukemia
2004
Molecular Mechanisms of Mammalian DNA Repair and the DNA Damage Checkpoints
2004 StandoutNobel
Metal-Free Multicomponent Syntheses of Pyridines
2014 Standout
Multiple Binding Modes of Inhibitors to Carbonic Anhydrases: How to Design Specific Drugs Targeting 15 Different Isoforms?
2012 Standout
Works of Udo Kellner being referenced
Expression of human beta-defensins 1 and 2 in kidneys with chronic bacterial infection
2002
Expression of carbonic anhydrase IX in human pancreatic cancer
2003
TGF-β: An emerging player in drug resistance
2013
High topoisomerase IIα expression associates with high proliferation rate and and poor prognosis in oligodendrogliomas
2000
Interactions between human colon carcinoma cells, fibroblasts and monocytic cells in coculture—regulation of cathepsin B expression and invasiveness
2004
Ki-A10, a Germ Cell Nuclear Antigen Retained in a Subset of Germ Cell-Derived Tumors
1999
Human DNA-Topoisomerases – Diagnostic and Therapeutic Implications for Cancer
2000
Growth factors in human prostate cancer cells: Implications for an improved treatment of prostate cancer
1991
Erasure of Western Blots After Autoradiographic or Chemiluminescent Detection
1998
Culprit and victim – DNA topoisomerase II
2002
Up‐regulation of cathepsin X in prostate cancer and prostatic intraepithelial neoplasia
2004
Up‐regulation of cathepsin X in Helicobacter pylori gastritis and gastric cancer
2005
Decreased drug accumulation in a mitoxantrone-resistant gastric carcinoma cell line in the absence of P-glycoprotein
1997
Parallel screening for ALK, MET and ROS1 alterations in non-small cell lung cancer with implications for daily routine testing
2014
Cathepsin L antisense oligonucleotides in a human osteosarcoma cell line: Effects on the invasive phenotype
2001
Detection of Human Topoisomerase IIα in Cell Lines and Tissues: Characterization of Five Novel Monoclonal Antibodies
1997
Prognostic relevance of a novel proliferation marker, Ki-S11, for soft-tissue sarcoma. A multivariate study.
1997